HPGM also started the Board Pipeline Initiative in 2016 with the Greater Milwaukee Fund.
HPGM's most recent priority has been a workforce study partnership with the Wisconsin Policy Forum.
HPGM's main goal is to build partnerships, whether they be with large corporations, small nonprofit groups or individual people.
In this work, the differentiated cells in all but StemPro (Ser1-7) and HPGM media had similar histamine content to that of in vivo MCs, and varied between 0.6 and 2.3 pg/cell.
As shown in Figure 2, in the media where serum was added at the first week of culture, there was no significant difference in c-kit expression; however, there was a 1.6 [+ or -] 0.1and 1.8 [+ or -] 0.1-fold increase in c-kit density (MFI, p < 0.05) for StemSpan and HPGM compared to StemPro, respectively.
StemSpan showed a higher cell yield (more than two-fold) than StemPro and HPGM (p < 0.05, Figure 4(b)).
CD90 expression was higher for fibroblasts in StemPro compared to StemSpan and HPGM (p < 0.05).
As shown in Figure 4(e), the fibroblasts released IL-6 in a media-dependent manner, with more than two-fold higher release for the cells cultured in StemSpan, compared to the release from fibroblasts cultured in StemPro and HPGM (p < 0.05).